Rose Ackermann

1.3k citations
29 papers · 983 indexed · h-index 19

Impact in

Papers in

Rose Ackermann

29 papers receiving 956 citations

Peers

Rose Ackermann
Comparison fields: 5 of 99
  • Pharmaceutical Science 324
  • Biomaterials 226
  • Molecular Medicine 50
  • Endocrinology, Diabetes and Metabolism 140
  • Cancer Research 102
Replace Minzhi Yu with:
Minzhi Yu United States
Huijie An China
Sharon Pangburn United States
Juan Cheng China
Maha M. Amin Egypt
Donghang Xu China
Mengyao Qin China
Maya Nair United States
Sachin Mittal India
Emily E. Morin United States
Rose Ackermann relative to Minzhi Yu United States Minzhi Yu's profile →
Citations per field
00.5×2.8×
Minzhi Yu · 1×
Citations per year

Countries citing papers authored by Rose Ackermann

Since Specialization
Citations

This map shows the geographic impact of Rose Ackermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Ackermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Ackermann more than expected).

Fields of papers citing papers by Rose Ackermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose Ackermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Ackermann. The network helps show where Rose Ackermann may publish in the future.

Co-authors

The 25 scholars most cited alongside Rose Ackermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rose Ackermann Line = papers co-authored together Rose Ackermann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201392
2 201777
3 201673
4 201669
5 202067
6 201764
7 200461
8 202051
9 201748
10 201841
11 201638
12 202033
13 202032
14 201627
15 201526
16 201625
17 202323
18 201720
19 202019
20 202118

About Rose Ackermann

Rose Ackermann is a scholar working on Pharmaceutical Science, Molecular Medicine, Structural Biology, Endocrinology, Diabetes and Metabolism and Biomaterials, having authored 29 papers that have together received 983 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (13 papers), Drug Solubulity and Delivery Systems (8 papers), Cholesterol and Lipid Metabolism (5 papers), Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Hydrogels: synthesis, properties, applications (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). The work is most often cited by research in Pharmaceutical Science (324 citations), Biomaterials (226 citations), Molecular Medicine (50 citations), Endocrinology, Diabetes and Metabolism (140 citations) and Cancer Research (102 citations). Rose Ackermann has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Anna Schwendeman, Karl Olsen, Steven P. Schwendeman, Jia Zhou, Jennifer Walker, Stephanie Choi, Keiji Hirota, Justin K. Y. Hong, Jie Tang and Yan Wang. Their work appears in journals such as Journal of Controlled Release, Molecular Pharmaceutics, International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics and Journal of Lipid Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026